LIFESPHERE®

The FDA’s Preferred Safety System

The FDA Selects ArisGlobal’s LifeSphere MultiVigilance, Medical Information, and Product Complaints for Their New Integrated Safety Platform

A Better and Modern FAERS Built with ArisGlobal

To build a better adverse event reporting system, the FDA replaces part of its pharmacovigilance system with LifeSphere MultiVigilance. 

LifeSphere MultiVigilance delivers the assured compliance, configurability, and flexibility needed to meet the Agency’s growing responsibility for protecting public health and safety.

The Chosen Next-Generation Safety System of the FDA and 9 Global Regulatory Authorities

Built with the Industry, for the Industry

For over 30 years, ArisGlobal has partnered with leading pharmaceutical companies and regulatory agencies to identify innovative ways to solve pharmacovigilance challenges.  

LifeSphere MultiVigilance 10 is the result of close coordination with top global life sciences organizations. Together with our partners, we’ve collaborated on a “best practice” out-of-the-box configuration, developed, tested and refined in real-world settings.

RESULTS

Delivering Real Results to a Global Client Base

80

%

Global Colaboration

80% of the top 50 pharma companies are our clients

80

%

Efficiency Gains

80% potential efficiency gains driven by our Nava cognitive computing engine

30

%

Cost Savings

30% immediate cost savings potential via our advanced automation capabilities

100

%

Compliance

100% compliance with all present and upcoming regulatory standards

Artificial Intelligence and Robotic Process Automation at Work

LifeSphere MultiVigilance 10 is the next-generation safety system from ArisGlobal. It combines artificial intelligence (AI) with robotic process automation (RPA) to help organizations streamline case processing and medical review, substantially reducing manual effort.  

This new platform is transformative for the FDA in its ability to automate key processes, incorporate the latest safety data standards and improve productivity, allowing reviewers to focus on public health and patient safety.

This transformational work will fundamentally improve health outcomes and positively impact mission performance.”

Sean Chaffee

Booz Allen Hamilton, FAERS Program Lead

Contact Us

By clicking ‘submit’ button, you are agreeing to opt-in to communications from ArisGlobal and use of the above information for ArisGlobal products, news & updates. Please note you can unsubscribe to email communication from ArisGlobal any time.